Increased ABCG2 efflux activity was observed under the same conditions, subsequently leading to reduced response to ABCG2 substrate anticancer drug.
glucose deprivation and hypoxia were also found to enhance the resistance level of abcg2-overexpressing resistant cells with pre-existing genetic and epigenetic mdr mechanisms.